MoFo Life Sciences

October 21, 2020 - AI + Robotics, COVID-19, FDA, Intellectual Property, Licensing + Commercial, Privacy + Data Security

Podcast: Applying AI and Data Science to the Fight Against COVID-19: The Science and Legal Considerations

By: Jean Nguyen, Kristen J. Mathews, Matthew Karlyn, Bethany J. Hills, and Michael R. Ward

In this second of a four-part podcast series on the science, regulatory framework, commercial transactions, and privacy and data security considerations of each unique aspect of the current health crisis, Michael Ward, MoFo partner and global head of the firm’s Life Sciences Group and …›

October 15, 2020 - FDA, Regulatory, United States

Bill Proposes Continuation of FDA Rare Pediatric Disease Priority Review Vouchers

By: Bethany J. Hills

Morrison & Foerster Research Analyst Christine Lentz contributed to the writing of this article. The House of Representatives recently passed a proposed bill that encourages treatments for rare pediatric diseases by prolonging the authority of Health and Human Services to issue priority review vouchers. H.R.4439, …›

October 13, 2020 - COVID-19, FDA, Intellectual Property, Licensing + Commercial, Privacy + Data Security

Podcast: Unpacking the Science and Legal Considerations of COVID-19 Testing

By: James J. Mullen III, Bethany J. Hills, Matthew Karlyn, Kristen J. Mathews, and Michael R. Ward

In this first of a four-part podcast series on the science, regulatory framework, commercial transactions, and privacy and data security considerations of each unique aspect of the current health crisis, Michael Ward, MoFo partner and global head of the firm’s Life Sciences Group and …›

October 7, 2020 - FDA, Intellectual Property, Litigation, United States

Navigating The CRISPR Patent Landscape and Understanding The FDA and its Process

By: Bethany J. Hills, Yan Qi, and Michael R. Ward

“What can be a better day to talk about the complex CRISPR/Cas9 patent landscape than the big day that the Nobel Prize was awarded to pioneers of this revolutionary technology? The story of the continuing dispute on the fundamental CRISPR/Cas9 patents offers a lot …›

October 1, 2020 - AI + Robotics, Intellectual Property, United States

Special Patents and AI with Janet Xiao and Anna Yuan

By: Janet Xiao, Anna Yuan, and Michael R. Ward

In this third installment of a six-part Patent Law Course offered by Morrison & Foerster and GSAS Harvard Biotech Club, MoFo partner and head of the firm’s China Life Sciences Group Janet Xiao taught a class on the value, protection, and legal issues involved …›

September 30, 2020 - Agtech, Asia, Pharma, Regulatory

China Technology Export Update: Amendment of The Export Technology Catalog

By: Can Cui

On August 28, 2020, China’s Ministry of Commerce (MOFCOM) and Ministry of Science and Technology (MOST) jointly published a notice on the adjustment of China’s Catalog of Technologies the Export of Which is Prohibited or Restricted (the “Catalog”). This is the first time the …›

September 28, 2020 - Intellectual Property, United States

Patent Drafting with James Mullen - GSAS Harvard Biotech Club & MoFo's Patent Course

By: James J. Mullen III and Michael R. Ward

Morrison & Foerster LLP partner, founder and head of MoFo’s antibody IP practice James Mullen taught a class in patent drafting to members of the GSAS Harvard Biotech Club (HBC). This was the second of a six-part Patent Law Course offered by Morrison & …›

September 23, 2020 - Asia, Intellectual Property, Regulatory

China Patent Linkage Update: Codification and Rulemaking

By: Can Cui

On July 3, 2020, China’s National People’s Congress published the second draft of the latest amendment to China’s Patent Law (the “Draft Amendment”) for public comments, which were allowed to be submitted by August 16, 2020. The Draft Amendment included proposed revisions to …›

September 22, 2020 - Data Analytics, FDA, Intellectual Property, Licensing + Commercial, Startup, United States

GSAS Harvard Biotech Club and Morrison & Foerster’s Patent Course Off to a Roaring Start!

By: Michael R. Ward, James J. Mullen III, Bethany J. Hills, Matthew Karlyn, Janet Xiao, Matthew A. Chivvis, Jie Zhou, Anna Yuan, Jillian A. Pesin-Fulop, and Yan Qi

More than 120 life sciences graduate students, post-docs and industry professionals attended the first class of a six part Patent Law Course offered by Morrison & Foerster and the GSAS Harvard Biotech Club on September 16, 2020. The Harvard Biotech Club is a student organization …›

September 17, 2020 - COVID-19, FDA, Healthcare, Product Liability + Class Action, United States

First Decisions Limit PREP Act Immunity in Coronavirus Context

By: Erin M. Bosman, Julie Y. Park, Bethany J. Hills, and Alexander A. Najarian

When we discussed the Public Readiness and Emergency Preparedness (PREP) Act earlier this year, we predicted that its tort liability protections would reassure manufacturers and distributors of novel COVID-19 drugs and medical products. So far, so good: the first court decisions interpreting PREP Act …›

1
2
3
4
5
6
7
8
9
10
Next.